Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Prospective registry for multifactorial risk factor assessment, enrolling consecutive ischemic stroke/transient ischemic attack patients with structural, inflammatory, or arrhythmogenic cardiac disease, who are admitted to our University Hospital.
The prospective registry shall provide new insights into the multiple associations, and respective therapeutic implications of cardio-vascular risk factors and stroke. For that reason consecutive patients with ischemic stroke/transient ischemic attack (brain, spinal cord, or retinal) and structural (e.g. patent foramen ovale), septic or aseptic endocarditis or myocarditis, or supra-ventricular or ventricular arrhythmia, who are admitted to our University Hospital, are enrolled. Multifactorial assessment of risk factors is based on medical history, laboratory biomarkers, electrocardiogram incl. cardiac autonomic function analysis, and (long-term) cardiac rhythm monitoring, as well as transthoracic and transesophageal echocardiography. Inclusion of follow-up visits permit longitudinal and prognostic evaluation of routine diagnostic and therapeutic interventions for secondary stroke prevention (e.g. implantable loop recorders or interventional closure of patent foramen ovale).
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Rate of any stroke | Recurrent ischemic stroke or intracranial hemorrhage during follow-up | ≥ 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Rate of mortality | Death from any cause during follow-up | ≥ 12 months |
| Rate of ischemic stroke | Ischemic stroke recurrence during follow-up |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Consecutive ischemic stroke/transient ischemic attack patients (brain, spinal crd, or retinal) with structural, inflammatory, or arrhythmogenic cardiac disease, who are admitted to our University Hospital.
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 26470854 | Result | Poli S, Diedler J, Hartig F, Gotz N, Bauer A, Sachse T, Muller K, Muller I, Stimpfle F, Duckheim M, Steeg M, Eick C, Schreieck J, Gawaz M, Ziemann U, Zuern CS. Insertable cardiac monitors after cryptogenic stroke--a risk factor based approach to enhance the detection rate for paroxysmal atrial fibrillation. Eur J Neurol. 2016 Feb;23(2):375-81. doi: 10.1111/ene.12843. Epub 2015 Oct 16. | |
| 33789756 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| D006331 | Heart Diseases |
| D054092 | Foramen Ovale, Patent |
| D001281 | Atrial Fibrillation |
| D054969 | Primary Dysautonomias |
| D000083242 | Ischemic Stroke |
| D002546 | Ischemic Attack, Transient |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| ≥ 12 months |
| Rate of transient ischemic attack | Transient ischemic attack recurrence during follow-up | ≥ 12 months |
| Rate of systemic embolism | Systemic embolism during follow-up | ≥ 12 months |
| Rate of myocardial infarction | Myocardial infarction during follow-up | ≥ 12 months |
| Rate of intracranial hemorrhage | Intracranial hemorrhage during follow-up | ≥ 12 months |
| Rate of major Bleedings | Major Bleedings during follow-up | ≥ 12 months |
| Rate of major or clinically relevant non-major bleedings | Major or clinically relevant non-major bleedings during follow-up | ≥ 12 months |
| Rate of serious adverse events | Serious adverse events during follow-up | ≥ 12 months |
| Rate of new-onset atrial fibrillation | Detection of atrial fibrillation during follow-up | ≥ 12 months |
| modified Rankin Score; range from 0 to 6, with '0' indicating the best outcome (i.e. no deficit), and '6' the worst outcome (i.e. death) | modified Rankin Scale score at follow-up | ≥ 12 months |
| Derived |
| Poli S, Siebert E, Mbroh J, Poli K, Krumbholz M, Mengel A, Greulich S, Hartig F, Muller KAL, Bocksch W, Gawaz M, Ziemann U, Zuern CS. Closure or medical therapy of patent foramen ovale in cryptogenic stroke: prospective case series. Neurol Res Pract. 2021 Apr 1;3(1):16. doi: 10.1186/s42466-021-00114-3. |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D006344 | Heart Septal Defects, Atrial |
| D006343 | Heart Septal Defects |
| D006330 | Heart Defects, Congenital |
| D018376 | Cardiovascular Abnormalities |
| D000013 | Congenital Abnormalities |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D001145 | Arrhythmias, Cardiac |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001342 | Autonomic Nervous System Diseases |
| D002545 | Brain Ischemia |